why do people stop taking glp-1 drugs Ever wonder what happens when you medications like Wegovy or Zepbound for weight loss? Get the facts. | UPMC What Happens When Patients Stop

Do I need to take them forever

It is a dual GIP/GLP-1 receptor agonist, meaning it acts on both the GIP and GLP-1 receptor pathways

Fogaa, M.V., Fukumoto, K., Franklin, T

These are complementary strategies that address weight through different biological pathways -- CagriSema through dual appetite suppression mechanisms, retatrutide through appetite suppression plus increased energy expenditure

Market Share Transformation The speed of Lillys market capture reflects several strategic advantages: Superior clinical efficacy drove physician preference changes Manufacturing scale-up met growing demand more effectively than competitors Pricing strategy balanced access with premium positioning Patient outcomes created strong word-of-mouth adoption Novos response has been constrained by the limitations of single-mechanism GLP-1 therapy and manufacturing capacity challenges